Cash · 2011–2025
Gilead Sciences cash
$7.6B−24.3% · FY2025
Gilead Sciences (GILD) reported $7.6B in cash for fiscal 2025, −24.3% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $7.6B | −24.3% | Open → |
| FY20242024-12-31 | $10.0B | +64.2% | Open → |
| FY20232023-12-31 | $6.1B | +12.4% | Open → |
| FY20222022-12-31 | $5.4B | +1.4% | Open → |
| FY20212021-12-31 | $5.3B | −11.0% | Open → |
| FY20202020-12-31 | $6.0B | −48.4% | Open → |
| FY20192019-12-31 | $11.6B | −35.2% | Open → |
| FY20182018-12-31 | $17.9B | +136.4% | Open → |
| FY20172017-12-31 | $7.6B | −7.8% | Open → |
| FY20162016-12-31 | $8.2B | −36.0% | Open → |
| FY20152015-12-31 | $12.9B | +28.2% | Open → |
| FY20142014-12-31 | $10.0B | +374.5% | Open → |
| FY20132013-12-31 | $2.1B | +17.1% | Open → |
| FY20122012-12-31 | $1.8B | −81.7% | Open → |
| FY20112011-12-31 | $9.9B | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −1.9%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Gilead Sciences cash |url=https://companiesranked.com/en/company/gilead-sciences/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Gilead Sciences cash. CompaniesRanked. https://companiesranked.com/en/company/gilead-sciences/cash-on-handBibTeX
@misc{companiesranked-en-company-gilead-sciences-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Gilead Sciences cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/gilead-sciences/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000882095-26-000031 · August 6, 2026
{{cite web |title=Gilead Sciences cash — 10-Q (0000882095-26-000031) |url=https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.